Latest Trials Latest NewsFAQ

NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Vegan vs AHA Diet on Inflammation and Glucometabolic Profile in Patients With CAD

Not Applicable

Completed

Conditions: Coronary Artery Disease
Inflammation

Interventions: Behavioral: Diet

First Posted Date: 2014-05-12

Last Posted Date: 2018-04-24

Lead Sponsor: NYU Langone Health

Target Recruit Count: 100

Registration Number: NCT02135939

Locations: 🇺🇸
NYUMC Tisch Hospital, HCC 14, New York, New York, United States

Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Phase 2

Completed

Conditions: Neurofibromatosis Type 2
Vestibular Schwannomas

Interventions: Drug: Axitinib

First Posted Date: 2014-05-02

Last Posted Date: 2021-12-01

Lead Sponsor: NYU Langone Health

Target Recruit Count: 13

Registration Number: NCT02129647

Locations: 🇺🇸
NYU Langone Medical Center, New York, New York, United States

The Human Epilepsy Project

Completed

Conditions: Focal Epilepsy

First Posted Date: 2014-04-30

Last Posted Date: 2021-07-06

Lead Sponsor: NYU Langone Health

Target Recruit Count: 488

Registration Number: NCT02126774

Locations: 🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
University of Texas, Houston, Texas, United States

and more 27 locations

Effect of Increasing Doses of Cystine Binding Thiol Drugs on Cystine Capacity in Patients With Cystinuria

Phase 4

Completed

Conditions: Cystinuria

Interventions: Drug: Tiopronin 1g per day
Drug: Tiopronin 2g per day
Drug: Tiopronin 3g per day

First Posted Date: 2014-04-29

Last Posted Date: 2021-08-23

Lead Sponsor: NYU Langone Health

Target Recruit Count: 10

Registration Number: NCT02125721

Locations: 🇺🇸
NYU Langone Medical Center, New York, New York, United States

Health-related Quality of Life in Rare Kidney Stone

Completed

Conditions: Cystinuria
Primary Hyperoxaluria
Adenine Phosphoribosyl Transferase Deficiency
Dent Disease

Interventions: Other: Health-related Quality of Life in Rare Kidney Stone Questionnaire

First Posted Date: 2014-04-28

Last Posted Date: 2022-09-02

Lead Sponsor: NYU Langone Health

Target Recruit Count: 365

Registration Number: NCT02124395

Locations: 🇺🇸
Primary Hyperoxaluria and Dent Disease Registry - Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
New York University School of Medicine - Cystinuria Registry, New York, New York, United States
🇮🇸
APRT Registry - Landspitali Universtiy Hospital, Reykjavik, Iceland

Cystine Capacity Clinical Study (CysCap)

Completed

Conditions: Cystinuria

First Posted Date: 2014-04-22

Last Posted Date: 2018-12-03

Lead Sponsor: NYU Langone Health

Target Recruit Count: 30

Registration Number: NCT02120105

Locations: 🇺🇸
NYU Langone Medical Center, New York, New York, United States

Concussion and Post Traumatic Stress in Traumatic Brain Injury

Terminated

Conditions: Stress Disorders, Post-Traumatic
Concussion

First Posted Date: 2014-04-21

Last Posted Date: 2017-11-07

Lead Sponsor: NYU Langone Health

Target Recruit Count: 1

Registration Number: NCT02119533

Locations: 🇺🇸
Bellevue HHC, New York, New York, United States

Platelet Activity in Vascular Surgery and Cardiovascular Events

Completed

Conditions: Cardiovascular Disease
Critical Limb Ischemia
Peripheral Artery Disease

First Posted Date: 2014-04-08

Last Posted Date: 2024-08-20

Lead Sponsor: NYU Langone Health

Target Recruit Count: 246

Registration Number: NCT02106429

Locations: 🇺🇸
NYU Langone Medical Center and School of Medicine, New York, New York, United States

Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department Patients

Phase 2

Completed

Conditions: Depression

Interventions: Drug: Ketamine
Drug: Diphenhydramine

First Posted Date: 2014-04-08

Last Posted Date: 2018-09-14

Lead Sponsor: NYU Langone Health

Target Recruit Count: 21

Registration Number: NCT02106325

Locations: 🇺🇸
Bellevue Hospital Center, New York, New York, United States
🇺🇸
NYU Langone Medical Center/Tisch Hospital, New York, New York, United States

Use of PET/MRI Tracer to Further Understanding of Prostate Cancer Development

Not Applicable

Completed

Conditions: Prostate Cancer
Bladder Cancer

Interventions: Procedure: PET/MRI

First Posted Date: 2014-04-08

Last Posted Date: 2017-10-11

Lead Sponsor: NYU Langone Health

Target Recruit Count: 21

Registration Number: NCT02106416

Locations: 🇺🇸
NYU Langone Medical Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy